Literature DB >> 20309946

Identification of EGFR mutations in lung sarcomatoid carcinoma.

Alvaro Leone, Paolo Graziano, Rita Gasbarra, Gregorino Paone, Giuseppe Cardillo, Andrea Mancuso, Filippo De Marinis, Serena Ricciardi, Luigi Portalone, Roberto Pisa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 20309946     DOI： 10.1002/ijc.25335

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  9 in total

1.  Epidermal growth factor receptor mutation heterogeneity analysis of pulmonary sarcomatoid carcinoma successfully treated with erlotinib: A case report.

Authors:  Fangwen Zou; Guiyuan Xie; Jin-An Ma; Dong-Ai Zhou; Y I Jiang; Jiao-Yun Zheng
Journal:  Oncol Lett       Date:  2015-03-18       Impact factor: 2.967

2.  Genomic origin and intratumor heterogeneity revealed by sequencing on carcinomatous and sarcomatous components of pulmonary sarcomatoid carcinoma.

Authors:  Xuewen Liu; Fang Wang; Chunwei Xu; Xinru Chen; Xue Hou; Qian Li; Pansong Li; Zhi Xie; Yongdong Liu; Lianpeng Chang; Yanfang Guan; Xuchao Zhang; Ling Yang; Hui Wang; Xin Yi; Jianjun Zhang; Xuefeng Xia; Cesar Moran; Likun Chen
Journal:  Oncogene       Date:  2020-12-03       Impact factor: 9.867

3.  EGFR and KRAS mutations in pulmonary pleomorphic carcinoma and their correlation with clinicopathologic features.

Authors:  Xiaoli Jia; Gang Chen
Journal:  Contemp Oncol (Pozn)       Date:  2015-03-26

4.  Clinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma.

Authors:  Xin Li; Dan Wang; Qingchun Zhao; Dian Ren; Fan Ren; Gang Chen; Hongyu Liu; Jun Chen
Journal:  Sci Rep       Date:  2017-06-21       Impact factor: 4.379

5.  [NP protocol taken for pulmonary sarcomatoid carcinoma: a case report].

Authors:  Yang Jiao; Chong Bai
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-06

6.  Genomic Variations and Immune-Related Features of TMB, PD-L1 Expression and CD8+ T Cell Infiltration in Chinese Pulmonary Sarcomatoid Carcinoma.

Authors:  Chenyue Zhang; Zhenxiang Li; Yanxiang Zhang; Chenglong Zhao; Hui Wang; Jiamao Lin; Cuicui Liu; Xiaohui Wang; Haiyong Wang
Journal:  Int J Gen Med       Date:  2022-04-20

7.  Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases.

Authors:  Si-Yuan Huang; Shu-Jing Shen; Xing-Ya Li
Journal:  World J Surg Oncol       Date:  2013-10-02       Impact factor: 2.754

8.  Response to gefitinib/crizotinib combination in a pulmonary sarcomatoid carcinoma patient harboring concurrent EGFR mutation and MET amplification.

Authors:  Xiaomeng Wang; Jie Cao; Weijiao Du; Weihong Zhang; Shui Cao
Journal:  Clin Case Rep       Date:  2021-07-23

9.  Prognostic factors in patients undergoing pulmonary resection for sarcomatoid carcinomas of the lung.

Authors:  Berker Özkan; Eren Erdoğdu; Salih Duman; Fahmin Amirov; Berk Çimenoğlu; Yasemin Özlük; Murat Kara; Dilek Yılmazbayhan; Alper Toker
Journal:  Balkan Med J       Date:  2021-03       Impact factor: 2.021
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.